Jasper Therapeutics to Reverse Split 1-for-30
Shares of the biotech company will be combined on November 6, 2026, to help maintain its Nasdaq Capital Market listing.
Updated on Nov. 4, 2026 in Corporate Finance
Jasper Therapeutics will effect a 1-for-30 reverse stock split of its common stock at 12:01 a.m. Eastern Time on November 6, 2026. The split follows stockholder approval at a September 30, 2026 special meeting and is intended to help the company regain or seek compliance with Nasdaq's minimum bid price requirement.
Why it matters
The reverse split is a corporate action aimed at raising the per-share price of Jasper's stock above the $1.00 Nasdaq threshold. Stockholders will see a smaller number of shares with a higher nominal price, with no change to the total value of their holdings at the time of the split.
Jasper shares outstanding will fall from approximately 33.3 million to approximately 1.11 million after the 1-for-30 ratio takes effect. The filing warns the market price may decline after the split or fail to stay above the $1.00 Nasdaq minimum, and that liquidity could fall.
The players
Jasper Therapeutics
A clinical-stage biopharmaceutical company based in Redwood City, California, whose common stock trades on the Nasdaq Capital Market.
Continental Stock Transfer & Trust Company
A transfer agent serving as the administrator of Jasper's stock records during the reverse split.
The details
Every thirty shares of common stock will be combined into one share, with cash paid in lieu of fractional shares based on the November 5, 2026 closing price. Shares held in book-entry form or through brokers will adjust automatically, and the split also applies proportionately to outstanding warrants and stock options. Continental Stock Transfer & Trust Company is serving as transfer agent.
Timeline
September 30, 2026: Stockholders approve the reverse split at a special meeting.
October 23, 2026: The board of directors approves the 1-for-30 ratio.
November 5, 2026: Closing price set for fractional share cash payments.
November 6, 2026, 12:01 a.m. ET: Reverse split takes effect and split-adjusted trading begins under JSPR with CUSIP 471871301.
Market Dynamics
Companies that fall below Nasdaq's $1.00 minimum bid price often turn to reverse splits to restore compliance with the exchange's listing rule. Jasper's 1-for-30 ratio is one such remedial step within that established listing framework.
Shareholders will hold fewer shares at a higher nominal price, and fractional shares will be settled in cash at the November 5, 2026 closing price. Holders with brokerage accounts need take no action, as their positions adjust automatically.
The takeaway
A reverse split changes the number of shares and their price but not the company's overall market value at the moment of the change. Investors should watch whether the post-split price holds above $1.00 and whether trading volume stays healthy.
What happens next
Split-adjusted trading under the symbol JSPR begins on November 6, 2026, when the new CUSIP 471871301 takes effect on the Nasdaq Capital Market.
Further reading
Explore more on how companies handle share structure changes in our Corporate Finance coverage.
Source note: This article includes information reported by The Manila times.
